Breaking News Instant updates and real-time market news.

CRSP

Crispr Therapeutics

$65.66

3.52 (5.66%)

08:46
11/26/19
11/26
08:46
11/26/19
08:46

Piper trims Crispr Therapeutics target to $104 on secondary dilution

To account for for dilution from last week's secondary offering, Piper Jaffray analyst Edward Tenthoff lowered his price target for Crispr Therapeutics to $104 from $107. The analyst, who notes Crispr's pro forma cash position is now $888M, reiterates an Overweight rating on the shares.

  • 07

    Dec

CRSP Crispr Therapeutics
$65.66

3.52 (5.66%)

11/19/19
WBLR
11/19/19
UPGRADE
WBLR
Outperform
Crispr Therapeutics upgraded to Outperform from Market Perform at William Blair
William Blair upgraded Crispr Therapeutics to Outperform from Market Perform.
11/19/19
WBLR
11/19/19
UPGRADE
WBLR
Outperform
William Blair upgrades Crispr Therapeutics to Outperform after 'impressive' data
William Blair analyst Raju Prasad upgraded Crispr Therapeutics to Outperform from Market Perform after the company presented initial results from the ongoing Phase I/II trials of CTX001 for the treatment of beta thalassemia and sickle cell disease. The stock in afternoon trading is up 18%, or $10.29, to $68.82. The analyst says today's data cut was "impressive" as it exceeds the 30% fetal hemoglobin threshold that he viewed as critical. To date, Crispr has shown initial proof-of-concept in beta thalassemia and sickle cell that exceeded expectations and de-risks its wholly owned immuno-oncology platform, Prasad tells investors in a research note. Further, given the "optionality" of the CRISPR-Cas9 platform and potential cost-effectiveness when compared with lentiviral-based therapies, Crispr could be a potential takeout candidate, adds the analyst.
11/20/19
ADAM
11/20/19
NO CHANGE
Target $80
ADAM
Buy
Crispr Therapeutics price target raised to $80 from $72 at Canaccord
Canaccord analyst Arlinda Lee raised her price target on Crisper Therapeutics to $80 from $72 following its release of positive hemoglobinopathy data. The price increase reflects the expected possibilities of success for its trials. Lee reiterated her Buy rating on Crisper Therapeutics shares.
11/25/19
OPCO
11/25/19
NO CHANGE
Target $80
OPCO
Outperform
Crispr Therapeutics price target raised to $80 from $65 at Oppenheimer
Oppenheimer analyst Silvan Tuerkcan raised his price target for Crispr Therapeutics to $80 from $65 after the company announced CTX001 results last week, saying the results overall surpassed his expectations, but patient number is only two. While this data is very preliminary, Tuerkcan tells investors in a research note that he believes it warrants read-across to other ex-vivo projects based on Crispr's ability to execute in manufacturing, cell transplants. He maintains an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

URBN

Urban Outfitters

$27.33

(0.00%)

, JBLU

JetBlue

$18.89

(0.00%)

09:40
12/11/19
12/11
09:40
12/11/19
09:40
Options
Unusually active option classes on open December 11th »

Unusual total active…

URBN

Urban Outfitters

$27.33

(0.00%)

JBLU

JetBlue

$18.89

(0.00%)

CHWY

Chewy

$25.55

(0.00%)

ATVI

Activision Blizzard

$55.94

(0.00%)

BA

Boeing

$347.86

(0.00%)

PTON

Peloton

$32.65

(0.00%)

HD

Home Depot

$215.84

(0.00%)

PCG

PG&E

$12.33

(0.00%)

CMCSA

Comcast

$42.77

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 13

    Dec

  • 07

    Jan

  • 25

    Feb

09:40
12/11/19
12/11
09:40
12/11/19
09:40
General news
The U.S. November CPI report »

The U.S. November CPI…

VCYT

Veracyte

$29.00

0.46 (1.61%)

09:36
12/11/19
12/11
09:36
12/11/19
09:36
Conference/Events
Veracyte management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

09:34
12/11/19
12/11
09:34
12/11/19
09:34
Conference/Events
Senate Commerce, Science & Transportation Committee holds executive session »

The Committee holds an…

ROAD

Construction Partners

$16.72

-3.84 (-18.68%)

09:33
12/11/19
12/11
09:33
12/11/19
09:33
Recommendations
Construction Partners analyst commentary  »

Construction Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRUP

Trupanion

$33.89

0.02 (0.06%)

09:33
12/11/19
12/11
09:33
12/11/19
09:33
Conference/Events
Trupanion management to meet with Lake Street »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

THTX

Theratechnologies

$3.05

-0.01 (-0.33%)

09:33
12/11/19
12/11
09:33
12/11/19
09:33
Upgrade
Theratechnologies rating change  »

Theratechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$2.94

0.03 (1.03%)

09:32
12/11/19
12/11
09:32
12/11/19
09:32
Hot Stocks
Akers Biosciences regains compliance with Nasdaq listing standards »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

SPB

Spectrum Brands

$61.63

-1.44 (-2.28%)

09:31
12/11/19
12/11
09:31
12/11/19
09:31
Conference/Events
Spectrum Brands management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

RMAX

RE/MAX Holdings

$39.09

0.24 (0.62%)

09:29
12/11/19
12/11
09:29
12/11/19
09:29
Conference/Events
RE/MAX Holdings management to meet with Craig-Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

PLPRF

Plus Products

$0.00

(0.00%)

09:28
12/11/19
12/11
09:28
12/11/19
09:28
Hot Stocks
Plus Products transitions to HERBL as primary California distribution partner »

Plus Products announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$146.12

-0.07 (-0.05%)

09:28
12/11/19
12/11
09:28
12/11/19
09:28
Periodicals
Disney+ eclipses 22M mobile downloads, CNBC reports »

Disney+ has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNTG

The Pennant Group

$27.98

1.49 (5.62%)

09:28
12/11/19
12/11
09:28
12/11/19
09:28
Conference/Events
The Pennant Group management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HD

Home Depot

$215.84

-0.75 (-0.35%)

09:26
12/11/19
12/11
09:26
12/11/19
09:26
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 25

    Feb

BIIB

Biogen

$297.05

1.58 (0.53%)

09:26
12/11/19
12/11
09:26
12/11/19
09:26
Conference/Events
SVB Leerink biotech analyst to hold analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PJT

PJT Partners

$42.80

0.2 (0.47%)

09:25
12/11/19
12/11
09:25
12/11/19
09:25
Conference/Events
PJT Partners management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 26

    Feb

MRMD

Marimed

$0.00

(0.00%)

09:25
12/11/19
12/11
09:25
12/11/19
09:25
Hot Stocks
Marimed to open dispensary in Middleborough, Massachusetts »

MariMed received final…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
12/11/19
12/11
09:25
12/11/19
09:25
General news
FOMC resumed its 2-day meeting »

FOMC resumed its 2-day…

09:25
12/11/19
12/11
09:25
12/11/19
09:25
Conference/Events
JPMorgan life science tools analyst to hold an analyst/industry conference call »

Life Science Tools &…

TREE

LendingTree

$324.87

-12.55 (-3.72%)

09:25
12/11/19
12/11
09:25
12/11/19
09:25
Conference/Events
LendingTree to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PFG

Principal Financial

$53.26

(0.00%)

09:25
12/11/19
12/11
09:25
12/11/19
09:25
Conference/Events
Principal Financial to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

FCEL

FuelCell

$0.53

0.014 (2.73%)

09:24
12/11/19
12/11
09:24
12/11/19
09:24
Initiation
FuelCell initiated  »

FuelCell reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Jan

PCTY

Paylocity

$120.35

-0.86 (-0.71%)

09:23
12/11/19
12/11
09:23
12/11/19
09:23
Conference/Events
Paylocity management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

TYHT

Shineco

$1.00

0.0099 (1.00%)

09:21
12/11/19
12/11
09:21
12/11/19
09:21
Hot Stocks
Shineco signs $10M industry hemp fiber preliminary processing sales contract »

Shineco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLNW

Limelight Networks

$4.03

-0.245 (-5.73%)

09:21
12/11/19
12/11
09:21
12/11/19
09:21
Recommendations
Limelight Networks analyst commentary  »

Limelight Networks price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.